APA (7th ed.) Citation

Gooderham, M., Bunick, C. G., Yu, J., Maslin, D., Schneider, S. K. R., Østerdal, M. L., . . . Eichenfield, L. F. (2026). Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial. Dermatology & Therapy, 16(7), 3275. https://doi.org/10.1007/s13555-026-01767-1

Chicago Style (17th ed.) Citation

Gooderham, Melinda, Christopher G. Bunick, JiaDe Yu, Douglas Maslin, Shannon K. R. Schneider, Marie Louise Østerdal, Anders Søhoel, Daniel Elenius Madsen, and Lawrence F. Eichenfield. "Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial." Dermatology & Therapy 16, no. 7 (2026): 3275. https://doi.org/10.1007/s13555-026-01767-1.

MLA (9th ed.) Citation

Gooderham, Melinda, et al. "Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial." Dermatology & Therapy, vol. 16, no. 7, 2026, p. 3275, https://doi.org/10.1007/s13555-026-01767-1.